Physician
Elterman, Lev
Elterman, Lev was paid $1.17M by Medicaid between Jan 2018 and Dec 2024, across 37 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 17% of everything it billed.
33Billing provider infoELTERMAN, LEV
SKOKIE, IL 60077
SKOKIE, IL 60077
33aNPI1851377113assigned 12/19/2005
33bProvider typeUrology Physician
28Total paid$1.17M
24GClaims65,091
24DCodes billed37
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Urology Physician providers in Illinois
Rank by total paid#1 of 219
Median peer was paid$5K
This provider vs. median223×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 8,244 | $70K | |
| 2019 | 7,064 | $52K | |
| 2020 | 8,341 | $117K | |
| 2021 | 10,921 | $217K | |
| 2022 | 11,390 | $270K | |
| 2023 | 9,335 | $194K | |
| 2024incomplete | 9,796 | $247K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 17% | 6,158 | 5,574 | $201K |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 13% | 7,965 | 7,380 | $154K |
| 52000 | 12% | 1,944 | 1,766 | $144K | |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 10% | 1,592 | 987 | $118K |
| 99244 | Office or other outpatient consultation, moderate to high complexity | 9.3% | 734 | 637 | $108K |
| 51798 | 7.7% | 10,819 | 10,079 | $90K | |
| 88121 | 6.2% | 639 | 609 | $73K | |
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 4.2% | 2,099 | 1,322 | $49K |
| 82570 | 3.5% | 9,605 | 7,737 | $41K | |
| 99204 | Doctor's office visit, new patient (more involved)Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity | 2.7% | 774 | 734 | $32K |
| 88112 | 2.7% | 999 | 965 | $31K | |
| U0005 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2 | 2.3% | 1,116 | 688 | $27K |
25 more codes
| 81003 | 1.6% | 9,539 | $19K | |
| 88313 | 1.5% | 1,010 | $18K | |
| 87811 | Infectious agent antigen detection by immunoassay; SARS-CoV-2 (COVID-19) | 1.4% | 404 | $17K |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | 1.2% | 423 | $14K |
| 76872 | <1% | 116 | $8K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 91 | $5K |
| 51741 | <1% | 232 | $4K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 102 | $4K |
| 99243 | <1% | 33 | $3K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 157 | $2K |
| 55700 | <1% | 19 | $2K | |
| 51784 | <1% | 45 | $1K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 35 | $796.71 |
| 84153 | <1% | 45 | $534.60 | |
| 36415 | Collection of venous blood by venipuncture | <1% | 653 | $188.43 |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 16 | $169.37 |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 41 | $168.56 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 21 | $137.34 |
| 99442 | <1% | 74 | $80.55 | |
| 99072 | <1% | 174 | $64.65 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 20 | $27.47 |
| G8427 | Eligible clinician attests to documenting in the medical record they obtained, updated, or reviewed the patient's current medications | <1% | 2,693 | $5.72 |
| 1111F | <1% | 2,091 | $3.14 | |
| G8420 | Bmi is documented within normal parameters and no follow-up plan is required | <1% | 2,269 | $0.08 |
| G8417 | Bmi is documented above normal parameters and a follow-up plan is documented | 0% | 344 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.